These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 26297533

  • 1. Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?
    Rossi AP, Zanardi E, Zamboni M, Rossi A.
    Drugs Aging; 2015 Sep; 32(9):679-87. PubMed ID: 26297533
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine.
    Contoli M, Corsico AG, Santus P, Di Marco F, Braido F, Rogliani P, Calzetta L, Scichilone N.
    COPD; 2017 Dec; 14(6):641-647. PubMed ID: 29116901
    [Abstract] [Full Text] [Related]

  • 6. Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD).
    Chalmers JD, Poole C, Webster S, Tebboth A, Dickinson S, Gayle A.
    Respir Res; 2018 Apr 11; 19(1):63. PubMed ID: 29642882
    [Abstract] [Full Text] [Related]

  • 7. The Effect on Total Mortality of Adding Inhaled Corticosteroids to Long-Acting Bronchodilators for COPD: A Real Practice Analysis in Italy.
    Di Martino M, Agabiti N, Cascini S, Kirchmayer U, Bauleo L, Fusco D, Belleudi V, Pinnarelli L, Voci C, Patorno E, Pistelli R, Davoli M, OUTPUL Study Group.
    COPD; 2016 Jun 11; 13(3):293-302. PubMed ID: 26514912
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI, Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Siddiqui S, Anzueto A, Zhu H.
    Int J Chron Obstruct Pulmon Dis; 2016 Jun 11; 11():1921-8. PubMed ID: 27574416
    [Abstract] [Full Text] [Related]

  • 10. Inhaled treatment of COPD: a Delphi consensus statement.
    Ninane V, Corhay JL, Germonpré P, Janssens W, Joos GF, Liistro G, Vincken W, Gurdain S, Vanvlasselaer E, Lehouck A.
    Int J Chron Obstruct Pulmon Dis; 2017 Jun 11; 12():793-801. PubMed ID: 28293106
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhaled Corticosteroids in Subjects with Chronic Obstructive Pulmonary Disease: An Old, Unfinished History.
    Melani AS, Croce S, Fabbri G, Messina M, Bargagli E.
    Biomolecules; 2024 Feb 06; 14(2):. PubMed ID: 38397432
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative Effectiveness of Long-Acting Beta2 -Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease.
    Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA.
    Pharmacotherapy; 2017 Apr 06; 37(4):447-455. PubMed ID: 28226405
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The place of inhaled corticosteroids in COPD].
    Chinet T, Dumoulin J, Honore I, Braun JM, Couderc LJ, Febvre M, Mangiapan G, Maurer C, Serrier P, Soyez F, Terrioux P, Jebrak G.
    Rev Mal Respir; 2016 Dec 06; 33(10):877-891. PubMed ID: 26831345
    [Abstract] [Full Text] [Related]

  • 19. [Bronchodilators in COPD: latest recommendations, recent data and perspectives].
    Roche N.
    Presse Med; 2004 Jan 31; 33(2):111-8. PubMed ID: 15026706
    [Abstract] [Full Text] [Related]

  • 20. C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD.
    Oshagbemi OA, Franssen FME, Wouters EFM, Maitland-van der Zee AH, Driessen JHM, de Boer A, de Vries F.
    Pulm Pharmacol Ther; 2020 Feb 31; 60():101870. PubMed ID: 31785343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.